title: Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.
authors.forename: K
authors.initials: K
authors.lastname: Stamatopoulos
authors.forename: T
authors.initials: T
authors.lastname: Papadaki
authors.forename: C
authors.initials: C
authors.lastname: Pontikoglou
authors.forename: I
authors.initials: I
authors.lastname: Athanasiadou
authors.forename: N
authors.initials: N
authors.lastname: Stavroyianni
authors.forename: J
authors.initials: J
authors.lastname: Bux
authors.forename: I
authors.initials: I
authors.lastname: Batsis
authors.forename: K
authors.initials: K
authors.lastname: Pyrovolaki
authors.forename: G
authors.initials: G
authors.lastname: Paterakis
authors.forename: D
authors.initials: D
authors.lastname: Anagnostou
authors.forename: A
authors.initials: A
authors.lastname: Anagnostopoulos
authors.forename: H A
authors.initials: HA
authors.lastname: Papadaki
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017209:Apoptosis; D001853:Bone Marrow / Q000473:pathology / Q000502:physiology*; D016207:Cytokines / Q000096:biosynthesis; D005260:Female; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D016131:Lymphocyte Subsets / Q000276:immunology*; D008223:Lymphoma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000473:pathology; D009503:Neutropenia / Q000139:chemically induced*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D016207:Cytokines; D000069283:Rituximab